ArticleTechnology in cancer research & treatment
Clinical Target Volume Auto-Segmentation of Esophageal Cancer for Radiotherapy After Radical Surgery Based on Deep Learning.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Performance of radiomics-based artificial intelligence systems in the diagnosis and prediction of treatment response and survival in esophageal cancer: a systematic review and meta-analysis of diagnostic accuracy.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2023Pooled it
- Hyperspectral reconstruction of white light endoscopy images for enhanced segmentation of early esophageal lesions in patients.iScience · 2026Article
- Deep learning-based independent lymph node segmentation in esophageal cancer: a precise and efficient approach for radiotherapy planning.Quantitative imaging in medicine and surgery · 2026Article
- Attention-Enhanced Multi-Task Deep Learning Model for Classification and Segmentation of Esophageal Lesions.ACS omega · 2025Article
- Current Role of Artificial Intelligence in the Management of Esophageal Cancer.Journal of clinical medicine · 2025Review
- Deep Learning for Image Analysis in the Diagnosis and Management of Esophageal Cancer.Cancers · 2024Review
- A deep learning-based 3D Prompt-nnUnet model for automatic segmentation in brachytherapy of postoperative endometrial carcinoma.Journal of applied clinical medical physics · 2024Article
- Review of Deep Learning Based Autosegmentation for Clinical Target Volume: Current Status and Future Directions.Advances in radiation oncology · 2024Review
- Global research trends of artificial intelligence applied in esophageal carcinoma: A bibliometric analysis (2000-2022)Frontiers in oncology · 2022Article
- Deep Learning for Automated Contouring of Gross Tumor Volumes in Esophageal Cancer.Frontiers in oncology · 2022Article
- Multi-Task Model for Esophageal Lesion Analysis Using Endoscopic Images: Classification with Image Retrieval and Segmentation with Attention.Sensors (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiotherapy plays an important role in controlling the local recurrence of esophageal cancer after radical surgery. Segmentation of the clinical target volume is a key step in radiotherapy treatment planning, but it is time-consuming and operator-dependent. This paper introduces a deep dilated convolutional U-network to achieve fast and accurate clinical target volume auto-segmentation of esophageal cancer after radical surgery. The deep dilated convolutional U-network, which integrates the advantages of dilated convolution and the U-network, is an end-to-end architecture that enables rapid training and testing. A dilated convolution module for extracting multiscale context features containing the original information on fine texture and boundaries is integrated into the U-network architecture to avoid information loss due to down-sampling and improve the segmentation accuracy. In addition, batch normalization is added to the deep dilated convolutional U-network for fast and stable convergence. In the present study, the training and validation loss tended to be stable after 40 training epochs. This deep dilated convolutional U-network model was able to segment the clinical target volume with an overall mean Dice similarity coefficient of 86.7% and a respective 95% Hausdorff distance of 37.4 mm, indicating reasonable volume overlap of the auto-segmented and manual contours. The mean Cohen kappa coefficient was 0.863, indicating that the deep dilated convolutional U-network was robust. Comparisons with the U-network and attention U-network showed that the overall performance of the deep dilated convolutional U-network was best for the Dice similarity coefficient, 95% Hausdorff distance, and Cohen kappa coefficient. The test time for segmentation of the clinical target volume was approximately 25 seconds per patient. This deep dilated convolutional U-network could be applied in the clinical setting to save time in delineation and improve the consistency of contouring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.